Treatment with bortezomib of a patient having hyper IgG4 disease.

Abstract

Hyper IgG4 disease is a recently described inflammatory disease characterized by lymphoplasmacytic infiltration leading to fibrosis and tissue destruction. Whereas most cases have been successfully treated with corticosteroids, recurrent or refractory cases may benefit from alternative therapies. Bortezomib has proven to be successful in the treatment of… (More)
DOI: 10.3816/CLML.2010.n.034

Topics

Cite this paper

@article{Khan2010TreatmentWB, title={Treatment with bortezomib of a patient having hyper IgG4 disease.}, author={M. Laeeq Khan and Thomas Vail Colby and Robert W. Viggiano and Rafael Le{\~a}o da Fonseca}, journal={Clinical lymphoma, myeloma & leukemia}, year={2010}, volume={10 3}, pages={217-9} }